Woman have a one in eight chance of developing breast cancer in their lifetime and although your yearly mammogram may not prevent breast cancer, early detection can save your life. Recent technologies such as 3D Breast Tomosynthesis and Molecular Breast Imaging have been developed to diagnose breast cancer in its earliest stages.
Digital Tomosynthesis is a new FDA approved screening that creates a 3-dimensional picture of the breast by taking multiple x-rays at many angles. The technology improves detection rates with greater accuracy in pinpointing size, shape and location; fewer biopsies are needed and earlier detection of smaller breast cancers are improved.
Molecular Breast Imaging is used primarily with patients who have more of a dense breast tissue. FDA approved since 1999, this technology is typically used in conjunction with mammography in high-risk and patients with prior diagnosis. MBI uses a radioactive tracer that is injected through the arm and “lights up” cancerous areas inside the breast. A camera is then used to scan the breast looking for areas where the radioactive substance is highly concentrated. Molecular Breast Imaging is widely available at healthcare facilities.